These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37882921)

  • 1. European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting.
    Schreuder K; Bult TJ; Stroop B; Koppert LB; Bijlsma RM; Bantema-Joppe EJ; Hoornweg MJ; Siesling S
    Breast Cancer Res Treat; 2024 Feb; 203(3):523-531. PubMed ID: 37882921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analytics.
    Hamersma DT; Schreuder K; Geleijnse G; Heeg E; Cellamare M; Lobbes MBI; Mureau MAM; Koppert LB; Skjerven H; Nygård JF; Groothuis-Oudshoorn CGM; Siesling S
    Breast Cancer Res Treat; 2023 Sep; 201(2):247-256. PubMed ID: 37355527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Naume B; Nygård JF
    Int J Med Inform; 2019 May; 125():102-109. PubMed ID: 30914174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Multiple Quality Indicators of Breast Cancer Care Toward Hospital Variation of a Summary Measure.
    Vos EL; Koppert LB; Jager A; Vrancken Peeters MTFD; Siesling S; Lingsma HF
    Value Health; 2020 Sep; 23(9):1200-1209. PubMed ID: 32940238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Case-Mix and Random Variation on Breast Cancer Care Quality Indicators and Their Rankability.
    Vos EL; Lingsma HF; Jager A; Schreuder K; Spronk P; Vrancken Peeters MTFD; Siesling S; Koppert LB
    Value Health; 2020 Sep; 23(9):1191-1199. PubMed ID: 32940237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
    van Dam PA; Tomatis M; Marotti L; Heil J; Mansel RE; Rosselli Del Turco M; van Dam PJ; Casella D; Bassani LG; Danei M; Denk A; Egle D; Emons G; Friedrichs K; Harbeck N; Kiechle M; Kimmig R; Koehler U; Kuemmel S; Maass N; Mayr C; Prové A; Rageth C; Regolo L; Lorenz-Salehi F; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Audisio R; Ponti A;
    Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Quality Indicators of Breast Cancer Management at a Tertiary Cancer Center in Nepal.
    Baral S; Silwal SR; Shrestha UM; Lamichhane D
    JCO Glob Oncol; 2022 Mar; 8():e2100303. PubMed ID: 35298295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality indicators for in-hospital pharmaceutical care of Dutch elderly patients: development and validation of an ACOVE-based quality indicator set.
    Wierenga PC; Klopotowska JE; Smorenburg SM; van Kan HJ; Bijleveld YA; Dijkgraaf MG; de Rooij SE
    Drugs Aging; 2011 Apr; 28(4):295-304. PubMed ID: 21428464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Ipsilateral Breast Tumor Recurrence as a Quality Indicator: Hospital Variation in the Netherlands.
    van der Heiden-van der Loo M; Siesling S; Wouters MW; van Dalen T; Rutgers EJ; Peeters PH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S522-8. PubMed ID: 25986872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit.
    van Bommel AC; Spronk PE; Vrancken Peeters MT; Jager A; Lobbes M; Maduro JH; Mureau MA; Schreuder K; Smorenburg CH; Verloop J; Westenend PJ; Wouters MW; Siesling S; Tjan-Heijnen VC; van Dalen T;
    J Surg Oncol; 2017 Mar; 115(3):243-249. PubMed ID: 27885679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.
    Kiderlen M; Ponti A; Tomatis M; Boelens PG; Bastiaannet E; Wilson R; van de Velde CJ; Audisio RA;
    Eur J Cancer; 2015 Jul; 51(10):1221-30. PubMed ID: 25892645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality indicators for the diagnosis and surgical management of breast cancer in South Africa.
    Nietz S; Ruff P; Chen WC; O'Neil DS; Norris SA
    Breast; 2020 Dec; 54():187-196. PubMed ID: 33120084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality indicators for breast cancer care: A systematic review.
    Maes-Carballo M; Gómez-Fandiño Y; Reinoso-Hermida A; Estrada-López CR; Martín-Díaz M; Khan KS; Bueno-Cavanillas A
    Breast; 2021 Oct; 59():221-231. PubMed ID: 34298301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
    Houzard S; Courtois E; Le Bihan Benjamin C; Erbault M; Arnould L; Barranger E; Coussy F; Couturaud B; Cutuli B; de Cremoux P; de Reilhac P; de Seze C; Foucaut AM; Gompel A; Honoré S; Lesur A; Mathelin C; Verzaux L; Bousquet PJ
    Clin Breast Cancer; 2022 Oct; 22(7):e832-e841. PubMed ID: 35750594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Care Quality Indicators in Spain: A Systematic Review.
    Maes-Carballo M; Gómez-Fandiño Y; Estrada-López CR; Reinoso-Hermida A; Khan KS; Martín-Díaz M; Bueno-Cavanillas A
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34199302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.
    Powis M; Sutradhar R; Gonzalez A; Enright KA; Taback NA; Booth CM; Trudeau M; Krzyzanowska MK
    Cancer; 2017 Oct; 123(19):3772-3780. PubMed ID: 28678343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.
    Kilsdonk MJ; van Dijk BA; Otter R; van Harten WH; Siesling S
    BMC Cancer; 2014 Aug; 14():596. PubMed ID: 25129126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer care and surgery in Australia and New Zealand: compliance of the BreastSurgANZ quality audit with international standards.
    Duffield JA; Blanch AJ; Bochner MA
    ANZ J Surg; 2023 Apr; 93(4):881-888. PubMed ID: 36856199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality improvement by implementing an integrated oncological care pathway for breast cancer patients.
    van Hoeve J; de Munck L; Otter R; de Vries J; Siesling S
    Breast; 2014 Aug; 23(4):364-70. PubMed ID: 24582455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit.
    Spronk PER; van Bommel ACM; Siesling S; Wouters MWJM; Vrancken Peeters MTFD; Smorenburg CH
    Breast; 2017 Dec; 36():34-38. PubMed ID: 28942098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.